Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PolyPEPI1018 in metastatic colorectal cancer
NCT03391232Phase 2Completed
- Sponsor
- Treos Bio
- Start
- May 2018
- Primary completion
- Jul 2019
- Modality
- Prophylactic Vaccines, Peptides, Peptide-based Cancer Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of PolyPEPI1018 in metastatic colorectal cancer (mCRC), sponsored by Treos Bio. Started May 2018; status: completed.
02
Drugs
PolyPEPI1018
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03391232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03391232.